Institutional Translation Partnership Award (iTP A): University of Cambridge (360G-Wellcome-209749_Z_17_Z)


The University of Cambridge is committed to achieving excellence in research and scholarship and ensuring that our research contributes to the wellbeing of society. The Cambridge bioscience cluster is the largest outside of the US, and third largest in the world, which, together with our multidisciplinary research strengths indicates tremendous potential to further build on the translational biomedical research activity at the University. The aims in working with the Wellcome Trust iTPA are to stimulate the translatable ideas pipeline across the breadth of relevant research at the University of Cambridge, and enable the early collaborative partnerships (industry and/or clinical medicine) that are essential in successful delivery of translational biomedicine. There will be an initial focus on chemical biology and resource will be deployed to conduct translational workshops, provide Cambridge scientists with flexible support and access to medicinal chemistry experts and bring together cross disciplinary and cross sector groups via challenge-led workshops. This will be complemented by a proof of concept funding scheme which will focus on funding cross-disciplinary collaborative projects.

Where is this data from?

This data was originally published by The Wellcome Trust. If you need to report a problem in the data please contact The Wellcome Trust directly, see their GrantNav publisher page for more information.

Grant Details

Amount Awarded 1000000
Applicant Surname Abell
Approval Committee Internal Decision Panel
Award Date 2017-09-30T00:00:00+00:00
Financial Year 2016/17
Grant Programme: Title Innovations Translational Partnership Award
Internal ID 209749/Z/17/Z
Lead Applicant Prof Christopher Abell
Planned Dates: End Date 2021-01-15T00:00:00+00:00
Planned Dates: Start Date 2018-01-15T00:00:00+00:00
Recipient Org: Country United Kingdom
Region East of England